{"id":46480,"date":"2025-11-11T20:58:46","date_gmt":"2025-11-11T12:58:46","guid":{"rendered":"https:\/\/flcube.com\/?p=46480"},"modified":"2025-11-11T20:58:47","modified_gmt":"2025-11-11T12:58:47","slug":"gan-lee-transfers-medtech-control-to-hillhouse-investment-accelerating-drug-delivery-innovation","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=46480","title":{"rendered":"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation"},"content":{"rendered":"\n<p><strong>Gan &amp; Lee Pharmaceuticals (<a href=\"https:\/\/www.google.com\/finance\/quote\/603087:SHA\">SHA: 603087<\/a>)<\/strong> announced today that it has transferred its controlling stake in its wholly\u2011owned subsidiary, <strong>Gangan Medical Technology Jiangsu Co., Ltd.<\/strong> (Gangan MedTech) to <strong>Hillhouse Investment<\/strong>. The move aligns with Gan &amp; Lee\u2019s strategy to consolidate its core pharmaceutical business while allowing Hillhouse to prop up MedTech\u2019s global growth trajectory.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-transaction-highlights\">Transaction Highlights<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Ownership Transfer<\/strong> \u2013 Gan &amp; Lee will retain a minority holding in MedTech; Hillhouse acquires 100\u202f% of the remaining equity.<\/li>\n\n\n\n<li><strong>Capital Deployment<\/strong> \u2013 Proceeds will fund strategic R&amp;D in endocrine and metabolic therapeutics, bolstering Gan &amp; Lee\u2019s innovative drug pipeline.<\/li>\n\n\n\n<li><strong>Operational Synergy<\/strong> \u2013 Hillhouse\u2019s expertise in medical\u2011device operations will accelerate MedTech\u2019s manufacturing scale\u2011up, R&amp;D integration, and market expansion.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-medtech-s-value-proposition\">MedTech\u2019s Value Proposition<\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Specialization<\/strong> \u2013 Pioneering high\u2011quality drug delivery devices with FDA and EU CE MDR certification.<\/li>\n\n\n\n<li><strong>Quality Framework<\/strong> \u2013 Robust international\u2011standard compliance and quality\u2011management system.<\/li>\n\n\n\n<li><strong>Innovation Pipeline<\/strong> \u2013 Continuous product development aimed at addressing unmet needs in drug delivery.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\" id=\"h-forward-looking-statements\">Forward\u2011Looking Statements<\/h3>\n\n\n\n<p>This release contains forward\u2011looking statements regarding the transaction, potential future collaborations, and related market developments. These statements are based on current expectations and involve risks and uncertainties that could cause actual results to differ materially.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Gan &amp; Lee Pharmaceuticals (SHA: 603087) announced today that it has transferred its controlling stake&#8230;<\/p>\n","protected":false},"author":1,"featured_media":46482,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[20,421,4451,1120],"class_list":["post-46480","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-finance","tag-gan-lee-pharmaceuticals","tag-gangan-medical-technology","tag-sha-603087"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"Gan &amp; Lee Pharmaceuticals (SHA: 603087) announced today that it has transferred its controlling stake in its wholly\u2011owned subsidiary, Gangan Medical Technology Jiangsu Co., Ltd. (Gangan MedTech) to Hillhouse Investment. The move aligns with Gan &amp; Lee\u2019s strategy to consolidate its core pharmaceutical business while allowing Hillhouse to prop up MedTech\u2019s global growth trajectory.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=46480\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation\" \/>\n<meta property=\"og:description\" content=\"Gan &amp; Lee Pharmaceuticals (SHA: 603087) announced today that it has transferred its controlling stake in its wholly\u2011owned subsidiary, Gangan Medical Technology Jiangsu Co., Ltd. (Gangan MedTech) to Hillhouse Investment. The move aligns with Gan &amp; Lee\u2019s strategy to consolidate its core pharmaceutical business while allowing Hillhouse to prop up MedTech\u2019s global growth trajectory.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=46480\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-11-11T12:58:46+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-11T12:58:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1102-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation\",\"datePublished\":\"2025-11-11T12:58:46+00:00\",\"dateModified\":\"2025-11-11T12:58:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480\"},\"wordCount\":218,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1102-1.webp\",\"keywords\":[\"Finance\",\"Gan &amp; Lee Pharmaceuticals\",\"Gangan Medical Technology\",\"SHA: 603087\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46480#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=46480\",\"name\":\"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1102-1.webp\",\"datePublished\":\"2025-11-11T12:58:46+00:00\",\"dateModified\":\"2025-11-11T12:58:47+00:00\",\"description\":\"Gan & Lee Pharmaceuticals (SHA: 603087) announced today that it has transferred its controlling stake in its wholly\u2011owned subsidiary, Gangan Medical Technology Jiangsu Co., Ltd. (Gangan MedTech) to Hillhouse Investment. The move aligns with Gan & Lee\u2019s strategy to consolidate its core pharmaceutical business while allowing Hillhouse to prop up MedTech\u2019s global growth trajectory.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=46480\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1102-1.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/11\\\/1102-1.webp\",\"width\":1080,\"height\":608,\"caption\":\"Gan & Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=46480#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation - Insight, China&#039;s Pharmaceutical Industry","description":"Gan & Lee Pharmaceuticals (SHA: 603087) announced today that it has transferred its controlling stake in its wholly\u2011owned subsidiary, Gangan Medical Technology Jiangsu Co., Ltd. (Gangan MedTech) to Hillhouse Investment. The move aligns with Gan & Lee\u2019s strategy to consolidate its core pharmaceutical business while allowing Hillhouse to prop up MedTech\u2019s global growth trajectory.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=46480","og_locale":"en_US","og_type":"article","og_title":"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation","og_description":"Gan & Lee Pharmaceuticals (SHA: 603087) announced today that it has transferred its controlling stake in its wholly\u2011owned subsidiary, Gangan Medical Technology Jiangsu Co., Ltd. (Gangan MedTech) to Hillhouse Investment. The move aligns with Gan & Lee\u2019s strategy to consolidate its core pharmaceutical business while allowing Hillhouse to prop up MedTech\u2019s global growth trajectory.","og_url":"https:\/\/flcube.com\/?p=46480","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-11-11T12:58:46+00:00","article_modified_time":"2025-11-11T12:58:47+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1102-1.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=46480#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=46480"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation","datePublished":"2025-11-11T12:58:46+00:00","dateModified":"2025-11-11T12:58:47+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=46480"},"wordCount":218,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=46480#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1102-1.webp","keywords":["Finance","Gan &amp; Lee Pharmaceuticals","Gangan Medical Technology","SHA: 603087"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=46480#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=46480","url":"https:\/\/flcube.com\/?p=46480","name":"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=46480#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=46480#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1102-1.webp","datePublished":"2025-11-11T12:58:46+00:00","dateModified":"2025-11-11T12:58:47+00:00","description":"Gan & Lee Pharmaceuticals (SHA: 603087) announced today that it has transferred its controlling stake in its wholly\u2011owned subsidiary, Gangan Medical Technology Jiangsu Co., Ltd. (Gangan MedTech) to Hillhouse Investment. The move aligns with Gan & Lee\u2019s strategy to consolidate its core pharmaceutical business while allowing Hillhouse to prop up MedTech\u2019s global growth trajectory.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=46480#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=46480"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=46480#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1102-1.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1102-1.webp","width":1080,"height":608,"caption":"Gan & Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=46480#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Gan &amp; Lee Transfers MedTech Control to Hillhouse Investment, Accelerating Drug Delivery Innovation"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/11\/1102-1.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46480","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=46480"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46480\/revisions"}],"predecessor-version":[{"id":46483,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/46480\/revisions\/46483"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/46482"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=46480"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=46480"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=46480"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}